Jump to content
Sign in to follow this  

EGFR & ALK treatment with TECENTRIQ

Recommended Posts


A survival advantage for the TECENTRIQ and Avastin combination regimen was observed in all pre-specified exploratory patient subgroups analyzed, including people with EGFR and ALK mutations, liver metastases and those with varying levels of PD-L1 expression https://www.gene.com/media/press-releases/14722/2018-05-16/phase-iii-impower150-study-showed-genent



Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this